Rescue and sprouting of motoneurons following ventral root avulsion and reimplantation combined with intraspinal adeno-associated viral vector-mediated expression of glial cell line-derived neurotrophic factor or brain-derived neurotrophic factor

Experimental Neurology
B BlitsJoost Verhaagen

Abstract

Following avulsion of a spinal ventral root, motoneurons that project through the avulsed root are axotomized. Avulsion between, for example, L2 and L6 leads to denervation of hind limb muscles. Reimplantation of an avulsed root directed to the motoneuron pool resulted in re-ingrowth of some motor axons. However, most motoneurons display retrograde atrophy and subsequently die. Two neurotrophic factors, glial cell line-derived neurotrophic factor (GDNF) and brain-derived neurotrophic factor (BDNF), promote the survival of motoneurons after injury. The long-term delivery of these neurotrophic factors to the motoneurons in the ventral horn of the spinal cord is problematic. One strategy to improve the outcome of the neurosurgical reinsertion of the ventral root following avulsion would involve gene transfer with adeno-associated viral (AAV) vectors encoding these neurotrophic factors near the denervated motoneuron pool. Here, we show that AAV-mediated overexpression of GDNF and BDNF in the spinal cord persisted for at least 16 weeks. At both 1 and 4 months post-lesion AAV-BDNF- and -GDNF-treated animals showed an increased survival of motoneurons, the effect being more prominent at 1 month. AAV vector-mediated overexpression of n...Continue Reading

Citations

Oct 26, 2010·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·Martin M MortazaviNicholas Theodore
Feb 27, 2013·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Abel Torres-EspínXavier Navarro
Sep 30, 2008·Chinese Journal of Traumatology = Zhonghua Chuang Shang Za Zhi·Lei ChenFan Yang
Apr 25, 2006·Journal of Neurotrauma·Marc J RuitenbergGiles W Plant
Apr 25, 2006·Journal of Neurotrauma·Bas Blits, Mary Bartlett Bunge
Jan 8, 2009·Journal of Neurotrauma·Antonio ChiarettiEmanuele Ausili
Dec 17, 2008·Neurological Research·Andrew M HartMikael Wiberg
Dec 17, 2008·Neurological Research·Martijn R TannemaatMartijn Malessy
Jul 8, 2014·Therapeutic Delivery·Kenzo UchidaHisatoshi Baba
Jun 8, 2014·Experimental Neurology·Krisztián PajerAntal Nógrádi
Sep 30, 2015·The European Journal of Neuroscience·Ruben EggersJoost Verhaagen
Jul 1, 2008·Molecular and Cellular Neurosciences·Ruben EggersJoost Verhaagen
Dec 17, 2008·Biotechnology Journal·Dimitra Terzi, Venetia Zachariou
Apr 15, 2014·Biotechnology and Bioengineering·Yuewei Wu-FienbergMatthew D Wood
Oct 11, 2005·Physical Medicine and Rehabilitation Clinics of North America·B Jane Distad, Michael D Weiss
Sep 2, 2014·BioMed Research International·Davide PascalGiovanna Gambarotta
Sep 18, 2012·Experimental Neurology·N WeishauptK Fouad
Jul 23, 2013·European Journal of Pharmacology·Fred de WinterJoost Verhaagen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell-Type-Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Cell-Type Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Cell-Type-Specific Viral Vectors (ASM)

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.